COPAXONE® (glatiramer acetate injection) is used to treat relapsing forms of multiple sclerosis (MS). It is a subcutaneous injection made with a nonpyrogenic solution, 20 mg or 40 mg of glatiramer acetate, and 40 mg of the inactive ingredient mannitol.1
COPAXONE® (glatiramer acetate injection) Current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc.
Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.
autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only. Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.